Teva Pharmaceutical Industries (TEVA) Goodwill (2009 - 2026)

Teva Pharmaceutical Industries (TEVA) has reported Goodwill for 18 consecutive years, with $15.8 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Goodwill fell 0.69% year-over-year to $15.8 billion; the trailing twelve-month figure through Jun 2026 stood at $15.8 billion (down 0.69% YoY), and the FY2025 full-year result was $16.0 billion, changed 0.0% from the prior year.
• Goodwill held at $15.8 billion in Q2 2026 per TEVA's latest filing, from $15.8 billion in the prior quarter.
• Across five years, Goodwill topped out at $20.0 billion in Q1 2022 and bottomed at $15.5 billion in Q1 2025.
• Historically, Goodwill has averaged $16.9 billion across 5 years, with a median of $16.7 billion in 2023.
• The sharpest annual moves came in 2023 and 2026: Goodwill slipped 10.94% in 2023, then increased 2.23% in 2026.
• Over 5 years, Goodwill stood at $17.2 billion in 2022, then changed by 0.0% to $17.2 billion in 2023, then decreased by 6.85% to $16.0 billion in 2024, then changed by 0.0% to $16.0 billion in 2025, then dropped by 1.01% to $15.8 billion in 2026.
• According to Business Quant data, Goodwill over the past three periods registered $15.8 billion, $15.8 billion, and $16.0 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.